$4.80
0.09[1.91%]
At close: Apr 26
$4.80
0[0.00%]
After Hours: 4:20PM EDT
MeiraGTx Hldgs
(NASDAQ:MGTX)Latest News for MeiraGTx Hldgs Stock (NASDAQ:MGTX)
MeiraGTx Hldgs Stock (NASDAQ: MGTX)
Categories: All
Friday, March 15, 2024
Thursday, March 14, 2024
Tuesday, February 13, 2024
Thursday, December 21, 2023
- Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Dec 21, 2023, 1:01PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Dec 21, 2023, 12:32PM
- Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?Vandana Singh - Dec 21, 2023, 11:11AM
- MeiraGTx shares are trading higher after the company announced an asset purchase agreement involving its AAV-RPGR collaboration for up to $415 million.Benzinga Newsdesk - Dec 21, 2023, 9:27AM
- MeiraGTx Holdings Inked A Asset Purchase Agreement With Janssen Pharmaceuticals For Acquiring Remaining Stake In Botaretigene Sparoparvovec (Bota-vec) For The Treatment Of X-linked Retinitis Pigmentosa (XLRP) For $415MBenzinga Newsdesk - Dec 21, 2023, 7:05AM
Friday, December 08, 2023
Tuesday, November 14, 2023
- MeiraGTx Hldgs: Q3 Earnings InsightsBenzinga Insights - Nov 14, 2023, 9:35AM
- As Of September 30, 2023, MeiraGTx Had Cash And Cash Equivalents Of Approximately $64M, Which Is expected To Be Sufficient To Fund Operating Expenses And Capital Expenditure Requirements Into Mid-2025Benzinga Newsdesk - Nov 14, 2023, 8:15AM
- MeiraGTx Hldgs Q3 EPS $(0.74) Misses $(0.55) Estimate, Sales $5.10M Beat $3.27M EstimateBenzinga Newsdesk - Nov 14, 2023, 8:14AM
Monday, October 30, 2023
- Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Oct 30, 2023, 1:55PM
- Why Is Gene Therapy Company MeiraGTx Stock Trading Higher Today?Vandana Singh - Oct 30, 2023, 1:25PM
- MeiraGTx Holdings shares are trading higher after the company announced Sanofi made a $30 million strategic investment through the purchase of 4 million shares at a price of $7.50 per share.Benzinga Newsdesk - Oct 30, 2023, 10:35AM
- MeiraGTx Announces $30M Strategic Investment from Sanofi Via Purchase of 4M Shares At $7.50/ShareBenzinga Newsdesk - Oct 30, 2023, 7:37AM
Tuesday, October 24, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
Tuesday, August 01, 2023
Wednesday, July 19, 2023
- MeiraGTx shares are trading higher after the company announced it received a Commercial Manufacturer's/Importer's Authorization for its Quality Control testing facility at its GMP manufacturing site.Benzinga Newsdesk - Jul 19, 2023, 11:15AM
- Meiragtx Announces Its Wholly-Owned Gene Therapy Manufacturing Facility In Shannon, Ireland Has Received Commercial MIA Authorization For QC TestingBenzinga Newsdesk - Jul 19, 2023, 8:35AM
Tuesday, June 27, 2023
Thursday, June 22, 2023
Tuesday, May 16, 2023
Friday, May 12, 2023
Thursday, May 11, 2023
Wednesday, May 03, 2023
Friday, March 24, 2023
Thursday, March 23, 2023
Monday, March 20, 2023
Thursday, March 16, 2023
Wednesday, March 15, 2023
Tuesday, March 14, 2023
Tuesday, December 13, 2022
- MeiraGTx's Investigational Candidate Shows Improvement In Radiation Induced Dry Mouth SymptomsVandana Singh - Dec 13, 2022, 1:56PM
- MeiraGTx Announces 'Clinically meaningful improvements in xerostomia symptoms and disease burden reported in patient reported outcome (PRO) measures in both unilateral and bilateral cohorts'Benzinga Newsdesk - Dec 13, 2022, 7:34AM
- MeiraGTx Announces Clinical Data From AQUAx Phase 1 Clinical Study Of AAV2-hAQP1 For Treatment Of Grade 2/3 Radiation-Induced XerostomiaBenzinga Newsdesk - Dec 13, 2022, 7:34AM
Thursday, December 08, 2022
Thursday, November 10, 2022
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Nov 10, 2022, 11:29AM
- Meiragtx Holdings Plc Received $25.M Investment From Johnson & Johnson Innovation - JJDC, Investment Arm Of Johnson And Johnson; Updated Topline Data From The Phase 1/2 Trial Of Botaretigene Sparoparvovec For The Treatment Of X-linked Retinitis PigmentosaBenzinga Newsdesk - Nov 10, 2022, 8:25AM
- MeiraGTx Holdings Q3 EPS $(0.83) Down From $(0.59) YoY, Sales $4.82M Down From $6.95M YoYBenzinga Newsdesk - Nov 10, 2022, 8:04AM